Tone mix
Week by week 50 weeks
Share of Emergent Biosolutions, Inc.'s 115 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jan 26, 2026 · tone -100Former CEO of Gaithersburg's Emergent BioSolutions sued over alleged insider trading-121
- Week of Apr 13, 2026 · tone +100Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility+100
- Week of Mar 9, 2026 · tone -100Emergent Biosolutions (NYSE:EBS) Downgraded by Wall Street Zen to "Hold"-77
- Week of Sep 15, 2025 · tone +100Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner+68
- Week of Dec 1, 2025 · tone +100Emergent Biosolutions (NYSE:EBS) Stock Rating Upgraded by Wall Street Zen+64
- Week of May 11, 2026 · tone 0Emergent BioSolutions Stock Price, News, Quote & History-57
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Emergent Biosolutions, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 10 | 0 |
| Last 90 sessions | 32 | -4 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletComparing Monte Rosa Therapeutics (NASDAQ:GLUE) and Emergent Biosolutions (NYSE:EBS)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Comparing Monte Rosa Therapeutics (NASDAQ:GLUE) and Emergent Biosolutions (NYSE:EBS) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletCritical Survey: Emergent Biosolutions (NYSE:EBS) & Viridian Therapeutics (NASDAQ:VRDN)Neutral
- www.themarketsdaily.com · 1 outletCritical Analysis: Coherus Oncology (NASDAQ:CHRS) and Emergent Biosolutions (NYSE:EBS)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Critical Survey: Emergent Biosolutions (NYSE:EBS) & Viridian Therapeutics (NASDAQ:VRDN) | www.dailypolitical.com | 1 | Neutral |
| Critical Analysis: Coherus Oncology (NASDAQ:CHRS) and Emergent Biosolutions (NYSE:EBS) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead-To-Head Contrast: United Therapeutics (NASDAQ:UTHR) vs. Emergent Biosolutions (NYSE:EBS)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Contrast: United Therapeutics (NASDAQ:UTHR) vs. Emergent Biosolutions (NYSE:EBS) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 30, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletHead-To-Head Comparison: Emergent Biosolutions (NYSE:EBS) and Viridian Therapeutics (NASDAQ:VRDN)Neutral
- www.themarketsdaily.com · 1 outletEmergent Biosolutions (NYSE:EBS) versus Immatics (NASDAQ:IMTX) Financial SurveyNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Comparison: Emergent Biosolutions (NYSE:EBS) and Viridian Therapeutics (NASDAQ:VRDN) | www.themarketsdaily.com | 1 | Neutral |
| Emergent Biosolutions (NYSE:EBS) versus Immatics (NASDAQ:IMTX) Financial Survey | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, September 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletFinancial Contrast: Emergent Biosolutions (NYSE:EBS) and Precigen (NASDAQ:PGEN)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Contrast: Emergent Biosolutions (NYSE:EBS) and Precigen (NASDAQ:PGEN) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Emergent Biosolutions, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.